Although advances in the management of multiple myeloma have improved survival, treatment in the relapsed or refractory setting remains challenging. In this podcast Professor Paul Richardson and Professor Miles Prince talk through their considerations in the treatment of multiple myeloma and reflect on the differing perspectives that come from having a broader range of treatment ...
Podcast: Treating multiple myeloma is ‘a marathon, not a sprint’
6 Sep 2021
Sponsored by Amgen Australia Pty Ltd